362 related articles for article (PubMed ID: 28442507)
1. Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice.
Nuñez-Durán E; Chanclón B; Sütt S; Real J; Marschall HU; Wernstedt Asterholm I; Cansby E; Mahlapuu M
J Endocrinol; 2017 Jul; 234(1):15-27. PubMed ID: 28442507
[TBL] [Abstract][Full Text] [Related]
2. STK25 regulates oxidative capacity and metabolic efficiency in adipose tissue.
Sütt S; Cansby E; Paul A; Amrutkar M; Nuñez-Durán E; Kulkarni NM; Ståhlman M; Borén J; Laurencikiene J; Howell BW; Enerbäck S; Mahlapuu M
J Endocrinol; 2018 Sep; 238(3):187-202. PubMed ID: 29794231
[TBL] [Abstract][Full Text] [Related]
3. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M
Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of protein kinase STK25 in mice exacerbates ectopic lipid accumulation, mitochondrial dysfunction and insulin resistance in skeletal muscle.
Chursa U; Nuñez-Durán E; Cansby E; Amrutkar M; Sütt S; Ståhlman M; Olsson BM; Borén J; Johansson ME; Bäckhed F; Johansson BR; Sihlbom C; Mahlapuu M
Diabetologia; 2017 Mar; 60(3):553-567. PubMed ID: 27981357
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high-fat diet.
Cansby E; Amrutkar M; Mannerås Holm L; Nerstedt A; Reyahi A; Stenfeldt E; Borén J; Carlsson P; Smith U; Zierath JR; Mahlapuu M
FASEB J; 2013 Sep; 27(9):3660-71. PubMed ID: 23729594
[TBL] [Abstract][Full Text] [Related]
7. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
Cansby E; Magnusson E; Nuñez-Durán E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Ståhlman M; Howell BW; Marschall HU; Borén J; Mahlapuu M
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1723-1737. PubMed ID: 29930001
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans.
Amrutkar M; Kern M; Nuñez-Durán E; Ståhlman M; Cansby E; Chursa U; Stenfeldt E; Borén J; Blüher M; Mahlapuu M
Diabetologia; 2016 Feb; 59(2):341-53. PubMed ID: 26553096
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
[TBL] [Abstract][Full Text] [Related]
10. STK25 is a critical determinant in nonalcoholic steatohepatitis.
Amrutkar M; Chursa U; Kern M; Nuñez-Durán E; Ståhlman M; Sütt S; Borén J; Johansson BR; Marschall HU; Blüher M; Mahlapuu M
FASEB J; 2016 Oct; 30(10):3628-3643. PubMed ID: 27421788
[TBL] [Abstract][Full Text] [Related]
11. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
[TBL] [Abstract][Full Text] [Related]
12. TLR4 is required for the obesity-induced pancreatic beta cell dysfunction.
Li J; Chen L; Zhang Y; Zhang WJ; Xu W; Qin Y; Xu J; Zou D
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1030-8. PubMed ID: 23985305
[TBL] [Abstract][Full Text] [Related]
13. PI3Kγ ablation does not promote diabetes in
Breasson L; Sardi C; Becattini B; Zani F; Solinas G
FASEB J; 2018 Jan; 32(1):319-329. PubMed ID: 28904022
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Islet APJ Deletion Reduces Islet Density and Glucose Tolerance in Mice.
Han S; Englander EW; Gomez GA; Rastellini C; Quertermous T; Kundu RK; Greeley GH
Endocrinology; 2015 Jul; 156(7):2451-60. PubMed ID: 25965959
[TBL] [Abstract][Full Text] [Related]
15. Taurine supplementation prevents morpho-physiological alterations in high-fat diet mice pancreatic β-cells.
Ribeiro RA; Santos-Silva JC; Vettorazzi JF; Cotrim BB; Mobiolli DD; Boschero AC; Carneiro EM
Amino Acids; 2012 Oct; 43(4):1791-801. PubMed ID: 22418865
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes.
Devedjian JC; George M; Casellas A; Pujol A; Visa J; Pelegrín M; Gros L; Bosch F
J Clin Invest; 2000 Mar; 105(6):731-40. PubMed ID: 10727441
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study.
Heni M; Machann J; Staiger H; Schwenzer NF; Peter A; Schick F; Claussen CD; Stefan N; Häring HU; Fritsche A
Diabetes Metab Res Rev; 2010 Mar; 26(3):200-5. PubMed ID: 20225188
[TBL] [Abstract][Full Text] [Related]
18. Serine/threonine protein kinase 25 (STK25): a novel negative regulator of lipid and glucose metabolism in rodent and human skeletal muscle.
Nerstedt A; Cansby E; Andersson CX; Laakso M; Stančáková A; Blüher M; Smith U; Mahlapuu M
Diabetologia; 2012 Jun; 55(6):1797-807. PubMed ID: 22391949
[TBL] [Abstract][Full Text] [Related]
19. Depletion of protein kinase STK25 ameliorates renal lipotoxicity and protects against diabetic kidney disease.
Cansby E; Caputo M; Gao L; Kulkarni NM; Nerstedt A; Ståhlman M; Borén J; Porosk R; Soomets U; Pedrelli M; Parini P; Marschall HU; Nyström J; Howell BW; Mahlapuu M
JCI Insight; 2020 Dec; 5(24):. PubMed ID: 33170807
[TBL] [Abstract][Full Text] [Related]
20. Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice.
Nuñez-Durán E; Aghajan M; Amrutkar M; Sütt S; Cansby E; Booten SL; Watt A; Ståhlman M; Stefan N; Häring HU; Staiger H; Borén J; Marschall HU; Mahlapuu M
Hepatol Commun; 2018 Jan; 2(1):69-83. PubMed ID: 29404514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
